This grand round has already taken place.
Understanding muscarinic receptor activators for schizophrenia treatment
Dates and Times
Start: 11/29/2022 11:00 AM
End: 11/29/2022 12:00 PM
1. Understand the potential utility of muscarinic receptor activators for treatment of schizophrenia.
2. Understand the different mechanisms of action by which activators of M1 and M4 subtypes of muscaric receptors may provide efficacy in treatment of different symptoms of schizophrenia.
3. Understand the unique properties of positive allosteric modulators of muscarinic receptors that make them suitable as potential therapeutic agents.
Grand Round Files
Dr. Jeffrey Conn references for Nov. 29, 2022, Psychiatry Grand Rounds
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Please contact the Grand Round coordinator listed below: